Association study of schizophrenia with polymorphisms at six candidate genes

Schizophrenia Research
C VirgosE Vilella

Abstract

Clinical studies have shown that there is a genetic contribution to the pathogenesis of schizophrenia. The molecular mechanisms of effective antipsychotic drugs and recent advances in neural development suggest that several dopamine receptor, serotonin receptor and neurotrophic factor genes might be involved in the disorder. In this study, we assessed the associations between schizophrenia and polymorphisms in the D2 and D3 dopamine receptor (DRD2, DRD3), the serotonin 2A receptor (5HTR2A), the brain-derived neurotrophic factor (BDNF), the ciliary neurotrophic factor (CNTF) and the neurotrophin-3 (NT-3) genes. Our results suggest that the polymorphisms at the DRD3, 5HTR2A, CNTF and BDNF gene loci are unlikely to make our sample more genetically susceptible to schizophrenia. However, we found significant differences in microsatellite allele frequencies between schizophrenic and control groups for DRD2 in the whole sample and for DRD2 and NT-3 only in women. Therefore, clinical differences in the presentation of schizophrenia between gender might be related to genetic factors.

References

May 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·P Jones, R M Murray
Jul 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·I I Gottesman, J Shields
Aug 26, 1995·Lancet·D R Weinberger
May 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·S V FaraoneM T Tsuang
Jun 1, 1994·Acta Psychiatrica Scandinavica·S NankoH Kazamatsuri
Jan 1, 1996·Nature Genetics·C R CloningerN M Svrakic
Jun 1, 1996·Nature Genetics·M M NöthenM Rietschel
Jun 1, 1996·Nature Genetics·T LiD A Collier
Dec 1, 1995·Acta Psychiatrica Scandinavica·E DawsonP Wright
May 1, 1997·Acta Psychiatrica Scandinavica·E JŏnssonG Sedvall
Jan 1, 1997·Schizophrenia Bulletin·S O Moldin, I I Gottesman
May 28, 1998·Neuroreport·Y TanakaS Kuroda
Jun 4, 1998·Acta Psychiatrica Scandinavica·J ValeroA Labad

❮ Previous
Next ❯

Citations

Apr 12, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Gal Shoval, Abraham Weizman
Jul 24, 2002·Neuroscience Research·Chieko KatoTsukasa Sasaki
Jan 27, 2004·Schizophrenia Research·Hamid Mostafavi AbdolmalekyMing T Tsuang
Jan 27, 2004·Schizophrenia Research·Caroline DubertretPhilip Gorwood
Oct 8, 2014·Acta Neuropsychiatrica·Saliha Handan YildizEvrim Suna Arikan Terzi
Jul 14, 2010·Genetics and Molecular Research : GMR·S F TeeH C Loh
Dec 19, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·György SzekeresZoltán Janka
Feb 9, 2011·PM & R : the Journal of Injury, Function, and Rehabilitation·Kristin M Pearson-Fuhrhop, Steven C Cramer
Jun 18, 2010·Psychiatry Research·Lavinia AthanasiuSrdjan Djurovic
May 2, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Huiping ZhangJoel Gelernter
May 2, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·I Omer BarlasOzcan Uzun
Feb 13, 2013·European Journal of Clinical Investigation·Josep M AlegretJorge Joven
Jan 2, 2007·Biochemical and Biophysical Research Communications·Lulu QianLin He
Jun 26, 2014·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jinjing TanLian Gu
Nov 30, 2004·Schizophrenia Research·Silvana GalderisiMaria Del Zompo
Jul 28, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Sebnem PirildarFisun Akdeniz
Apr 4, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Erik G JönssonLars Terenius
Jun 14, 2005·Schizophrenia Research·Aleksandra SzczepankiewiczJoanna Hauser
Sep 11, 2009·Topics in Stroke Rehabilitation·Kristin M Pearson-FuhrhopSteven C Cramer
Sep 18, 2013·Psychiatry Research·Marija BoškovićTomaž Vovk
Oct 19, 2010·Neuroscience and Biobehavioral Reviews·Darrick T Balu, Joseph T Coyle
Jan 1, 2013·Neuroscience Letters·Agnes FehérZoltán Janka
Dec 1, 2011·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Jin-Sung ParkKang-Seob Oh
Sep 7, 2016·Nordic Journal of Psychiatry·Li SunYi-Ping Liu
Jan 15, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Pilar A SaizJulio Bobes
Apr 15, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Piotr M CzerskiJoanna Hauser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here